PRODUCT DETAILS

About Fillif Peg 6mg Injection

PEGFILGRASTIM belongs to the class of medicine called 'hematopoietic agent' used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases. PEGFILGRASTIM helps reduce the chance of infection in people with cancer and those receiving chemotherapy medicines. Neutropenia is a condition in which the quantity of neutrophils (a type of white blood cell) in the blood is reduced.

PEGFILGRASTIM contains 'Pegfilgrastim,' which is a growth factor that stimulates the formation of white blood cells and helps to reduce the chances of infection in cancer patients receiving chemotherapy.

PEGFILGRASTIM will be administered by a healthcare professional. In some cases, you may experience injection site responses such as pain, redness, or swelling. You may also experience nausea, headaches, bone pain and pain in the extremity. The majority of these side effects do not necessitate medical treatment and will fade gradually over time. However, if you suffer these side effects on a regular basis, you should consult your doctor.

Uses of Fillif Peg 6mg Injection

Neutropenia

Medicinal Benefits of Fillif Peg 6mg Injection

PEGFILGRASTIM contains 'Pegfilgrastim,' which is a growth factor. It belongs to the cytokine family of proteins and is extremely similar to a natural protein (granulocyte-colony stimulating factor) produced by the body. PEGFILGRASTIM acts by encouraging the bone marrow to generate more white blood cells, which aid in infection resistance. PEGFILGRASTIM is used to boost white blood cell count following cancer treatment or chemotherapy, bone marrow transplantation, severe persistent neutropenia, neutropenia in HIV patients, and before stem cell donation.

Directions for Use

PEGFILGRASTIM will be administered by a healthcare professional; do not self-administer.

Side Effects of Fillif Peg 6mg Injection

• Nausea
• Headaches
• Bone pain
• Pain in extremity
• Pain at the site of injection

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

Do not use PEGFILGRASTIM without the doctor's advice if you had a skin reaction or irritation to any medicine. Consult your doctor before using PEGFILGRASTIM if you are pregnant or breastfeeding. Let your doctor know if you are suffering from renal dysfunction, blood cancer, leucocytosis (high white blood cell count). Keep your doctor informed about your medical condition and all the medicines you are taking to rule out any side effects. Regular blood tests will be taken to monitor the number of white blood cells in the body. PEGFILGRASTIM is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees Celsius else its efficacy might get lost.

Drug Interactions

Drug-Drug Interaction:

 PEGFILGRASTIM may have interaction with medicines used to treat cancer (e.g. cladribine) and other hematopoietic agents (e.g. filgrastim).

Drug-Disease Interaction:

PEGFILGRASTIM may cause interactions with disease conditions such as glomerulonephritis (acute inflammation of the kidney), leucocytosis (high white blood cell count) and myeloid tumours (cancer).

Safety Advice

ALCOHOL

It is unknown whether consuming alcohol with PEGFILGRASTIM is safe. However, as a precaution, it is best to avoid or limit alcohol consumption.

PREGNANCY

Pregnancy Category C. It should be used in pregnant women only if clinically needed, and the benefits outweigh the risks. Please consult your doctor.

BREAST FEEDING

It is unknown whether PEGFILGRASTIM passes into the breast milk. Please seek medical advice from your doctor if you are breastfeeding before taking PEGFILGRASTIM.

DRIVING

The ability to drive or utilize machines is unaffected by PEGFILGRASTIM.

LIVER

Consult your doctor if you have liver problems.

KIDNEY

Caution should be exercised while using PEGFILGRASTIM in patients with renal dysfunction. Monitoring of patients with renal dysfunction is recommended.